A Phase 3, Open-Label, Multicenter, Single-Arm Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Dulaglutide 3.0 mg and 4.5 mg in Pediatric Participants 10 to Less than 18 Years of Age with Type 2 Diabetes Mellitus..

Project: Research

Status	Active
Effective start/end date	04/15/25 → 05/29/27

Project Details